New hand transplant protocol could reduce need for lifelong drugs
NCT ID NCT01459107
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests a new approach to hand and arm transplantation for people who have lost a hand or arm due to injury. The goal is to help the body accept the new limb while reducing the need for strong, lifelong anti-rejection drugs that can cause serious side effects. Up to 30 participants will receive a transplant along with a special immune treatment to see if they can eventually take fewer medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMPUTATION, TRAUMATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Johns Hopkins University School of Medicine
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.